These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
207 related items for PubMed ID: 36870517
21. Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement: A Systematic Review and Meta-analysis of Randomized Clinical Trials. Matharu GS, Kunutsor SK, Judge A, Blom AW, Whitehouse MR. JAMA Intern Med; 2020 Mar 01; 180(3):376-384. PubMed ID: 32011647 [Abstract] [Full Text] [Related]
22. Low risk of thromboembolic complications with tranexamic acid after primary total hip and knee arthroplasty. Gillette BP, DeSimone LJ, Trousdale RT, Pagnano MW, Sierra RJ. Clin Orthop Relat Res; 2013 Jan 01; 471(1):150-4. PubMed ID: 22814857 [Abstract] [Full Text] [Related]
24. Effectiveness and safety of rivaroxaban for the prevention of thrombosis following total hip or knee replacement: A systematic review and meta-analysis. Liu J, Zhao J, Yan Y, Su J. Medicine (Baltimore); 2019 Mar 01; 98(9):e14539. PubMed ID: 30817570 [Abstract] [Full Text] [Related]
30. Comparison of 90-Day Adverse Events Associated With Aspirin and Potent Anticoagulation Use for Venous Thromboembolism Prophylaxis: A Cohort Study of 72,288 Total Knee and 35,142 Total Hip Arthroplasty Patients. Singh G, Prentice HA, Winston BA, Kroger EW. J Arthroplasty; 2023 Aug 01; 38(8):1602-1612.e1. PubMed ID: 36805118 [Abstract] [Full Text] [Related]
33. Aspirin Administered for Venous Thromboembolism Prophylaxis May Protect Against Stiffness Following Total Knee Arthroplasty. Shohat N, Ludwick L, Sutton R, Chisari E, Parvizi J. J Arthroplasty; 2022 May 07; 37(5):953-957. PubMed ID: 35026368 [Abstract] [Full Text] [Related]
34. Factor Xa Inhibitors and Direct Thrombin Inhibitors Versus Low-Molecular-Weight Heparin for Thromboprophylaxis After Total Hip or Total Knee Arthroplasty: A Systematic Review and Meta-Analysis. Sun G, Wu J, Wang Q, Liang Q, Jia J, Cheng K, Sun G, Wang Z. J Arthroplasty; 2019 Apr 07; 34(4):789-800.e6. PubMed ID: 30685261 [Abstract] [Full Text] [Related]
35. Total Hip Arthroplasty in Patients Who Have Factor V Leiden: Elevated Risks Isolated to Venous Thromboembolism Events. Sanchez JG, Jiang WM, Dhodapkar MM, Radford ZJ, Rubin LE, Grauer JN. J Arthroplasty; 2024 Oct 07; 39(10):2421-2426. PubMed ID: 38838962 [Abstract] [Full Text] [Related]
37. Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study. Yhim HY, Lee J, Lee JY, Lee JO, Bang SM. PLoS One; 2017 Oct 07; 12(5):e0178214. PubMed ID: 28542415 [Abstract] [Full Text] [Related]